News - Teva Pharmaceutical Industries, Lupin

Filter

Popular Filters

US FDA approves first generic versions of antidepressant drug Cymbalta

US FDA approves first generic versions of antidepressant drug Cymbalta

12-12-2013

The US Food and Drug Administration yesterday approved the first generic versions of drug major Eli Lilly’s…

Aurobindo PharmaCymbaltaDr Reddy's LaboratoriesDuloxetine HclEli LillyGenericsLupinNeurologicalNorth AmericaRegulationSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

US FDA approves Lupin's generic version of Teva's Seasonique and Taro's Topicort

15-04-2013

Indian drugmaker Lupin (BSE: 500257) saw its shares gain 2.3% to 659.65 rupees by close of trading on…

DayseeDermatologicalsGenericsLupinMarkets & MarketingNorth AmericaPharmaceuticalRegulationReproductiveSeasoniqueTaro PharmaceuticalsTeva Pharmaceutical IndustriesTopicort

USPTO grants Pfizer reissue patent for Celebrex, extending term to Dec 2015

06-03-2013

Global pharma behemoth Pfizer (NYSE: PFE) said yesterday that the US Patent & Trademark Office has granted…

Anti-Arthritics/RheumaticsApotexCelebrexGenericsLupinMylan LaboratoriesNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesWatson Pharmaceuticals

Back to top